发明名称 |
R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDAN, SALTS, COMPOSITIONS AND USES THEREOF |
摘要 |
The subject invention provides R(+)-N-propargyl-1-aminoindan and pharmaceuti cally acceptable salts thereof, as well as pharmaceu- tical compositions containing same. Tbe subject invention also provides meth ods of treating a subject afflicted with Parkinson's dis ease, a memory disorder, dementia, depression, hyperactive syndrome, an affective illness, a neurodegenerative disease, a neurotoxic injur y, brain ischemia, a head trauma injury, a spinal trauma injury, schizophrenia, an attention deficit disorder, multiple sclerosis, or w ithdrawal symptoms, using R(+)-N-propargyl-1-aminoindan or the pharmaceutically accept able salt of the subject invention. The subject inventio n further provides a method of preventing nerve damage in a subject. Finally, the subject invention provides methods of preparing R(+) -N- propargyl-1-aminoindan, a salt thereof, and racemic N-propargyl-1-aminoindan .
|
申请公布号 |
CA2174449(C) |
申请公布日期 |
2007.01.16 |
申请号 |
CA19942174449 |
申请日期 |
1994.10.12 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TECHNION RESEARCH AND DEVELOPMENT FOUNDATION, LTD. |
发明人 |
YOUDIM, MOUSSA B. H.;FINBERG, JOHN P. M.;LEVY, RUTH;STERLING, JEFFREY;LERNER, DAVID;BERGER-PASKIN, TIRTSAH;YELLIN, HAIM;VEINBERG, ALEX |
分类号 |
A61P9/10;C07C211/42;A61K31/135;A61K31/137;A61K31/165;A61K31/195;A61K31/215;A61K45/06;A61P9/08;A61P25/00;A61P25/16;A61P25/18;A61P25/24;A61P25/26;A61P25/28;A61P25/30;A61P25/32;A61P27/02;A61P43/00;C07C211/30 |
主分类号 |
A61P9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|